https://techpapersworld.com/wp-content/uploads/2022/10/Wheeler-Bio-Announces-Initial-1280x720.jpg

Wheeler Bio, a contract development and manufacturing organization (CDMO) specializing in small batch clinical production of biologics and GMP-grade reagents using their open-source platform, Portable CMC™, today announced the first closing of their Series A financing round. The round was co-led by Charles River Laboratories and Echo Investment Capital with participation from ATUM, Floating Point Advisors, Plains Venture Partners (a subsidiary of i2E), and Pine Ridge Ventures. Wheeler Bio is solving for the typical momentum...